EC Number   |
Expression |
Reference |
|---|
    3.1.8.1 | down |
enzyme activities in fluorosis patients are considerably decreased up to 56.45% (mild), 61.5% (moderate) and 50% (severe) as compared to control group |
750345 |
| 3.1.8.1 | down |
enzyme activity is decreased in patients with autoimmune thyroid disease |
752150 |
| 3.1.8.1 | down |
enzyme levels of infants in fasting are significantly lower than the values in postprandial |
750482 |
| 3.1.8.1 | down |
enzyme levels of the patients with papillary thyroid cancer are significantly lower compared to those of the control group |
752173 |
| 3.1.8.1 | down |
mean values of serum paraoxonase-1 activity decrease significantly in stage 3 and stage 4 esophageal cancer patients compared with stage 2 esophageal cancer patients |
714895 |
| 3.1.8.1 | down |
paraoxonase activity is significantly lower in patients with chronic active hepatitis B compared to hepatitis B carrier patients or control group patients |
715738 |
| 3.1.8.1 | down |
serum paraoxonase activity is significantly lower in patients with metabolic syndrome than healthy subjects |
714893 |
| 3.1.8.1 | down |
the enzyme activity is reduced in Behcet's disease |
749840 |
| 3.1.8.1 | down |
there is a significant decrease of paraoxonase-1 activity of paraoxonase as a result of hypercholesterolemic diet feeding. Supplementation of rats with 3% (w/v) L-Arg in drinking water with standard diet or hypercholesterolemic diet markedly preserves enzymatic paraoxonase-1 activity in respect to rats receiving hypercholesterolemic diet without any treatment |
714002 |
| 3.1.8.1 | more |
analysis of the role of nuclear receptors in the regulation of PON1 expression |
750290 |
